Tern Plc
TERNF
Other OTC0.06
USD
- -
- -
ISIN
GB00BFPMV798
CUSIP
00BFPMV79
Return %
Stock
S&P500
1Y
-12.34
26.53
3Y
-19.25
76.60
5Y
-19.25
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Albert Ernest Sisto
- Full Time Employees
- 7
- Sector
- Technology
- Industry
- Software - Application
- Address
- 27/28 Eastcastle Street London United Kingdom W1W 8DH
- IPO Date
- May 15, 2019
- Website
- ternplc.com
- Similar Companies
- Business
- Tern Plc (LSE: TERN, OTCQX: TERNF) is a United Kingdom-based investment company that specializes in supporting high-growth, early-stage disruptive Internet of Things (IoT) technology businesses, with a primary focus on software companies developing commercial IoT security, enablement, and analytics solutions for healthcare and industrial sectors; its principal portfolio companies include Device Authority Limited, which provides KeyScaler and KeyScaler Edge platforms for identity and access management (IAM) in IoT across automotive, medical, industrial, and critical infrastructure sectors with integrations to Microsoft Azure, AWS, PTC ThingWorx, and Google Cloud; FundamentalVR (FVRVS Limited), offering a virtual reality, haptics, and data analytics platform for surgical education and training compatible with hardware from Meta, Apple, and Logitech, featuring AI-powered tutor Maia; Talking Medicines Limited, delivering Drug-GPT, an AI-driven healthcare intelligence platform using machine learning and natural language processing to analyze patient and healthcare professional data for pharmaceutical marketing insights; and interests in Sure Valley Ventures Enterprise Capital LP (SVV2), a venture capital fund targeting UK software firms in immersive technology, metaverse, AI, and cybersecurity, with portfolio companies such as Vortex IQ, Ittybit, Phinxt Robotics, Purple Transform, Stylus Education, and Vizgard; additional holdings encompass Wyld Networks AB for satellite IoT connectivity via Wyld Connect terminals and modules, and DiffusionData Limited for real-time data communication platforms. Founded in 2004 and headquartered at 27/28 Eastcastle Street, London W1W 8DH, United Kingdom, Tern operates principally within Europe while supporting portfolio companies with global ambitions, including expansions in North America, South America, Africa, the Middle East, and Asia-Pacific; it targets seed to Series B stage investments in quoted and unquoted technology firms, providing hands-on strategic support, management development, and follow-on funding to accelerate growth toward exits. Recent developments include Device Authority securing a second US$3.3 million tranche from Ten Eleven Ventures in December 2024 and partnering with Microsoft and CyberArk in March 2025 for NIST-compliant IoT security in manufacturing; FundamentalVR launching the American Academy of Ophthalmology VR program in Q4 2024, earning Best Surgery Training VR Technology Company 2024 and Fast Company’s Most Innovative Companies of 2025 recognition, alongside integrations with Apple Vision Pro and Logitech Stylus; Talking Medicines expanding U.S. partnerships with healthcare ad agencies and enhancing Drug-GPT capabilities; Tern investing an additional £0.5 million in SVV2 during 2024 to fund five new portfolio companies and acquiring a stake in Sure Ventures plc post-year-end in January 2025 for exposure to SVV1 and SVV2; Wyld Networks facing dilution from a 2024 rights issue, reducing Tern's holding to 0.6%, though achieving commercial L-Band product launch and partnerships in agriculture; and Konektio (InVMA Limited) entering administration in March 2024 with Tern's stake written off to zero value.